Gastrin hormone immunoassays
CA 2520010 C · Owner: Huntingdon Life Sciences Limited · Inventors: Little, John; Mcloughlin, Lorraine; Grimes, Stephen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides assay methods for the detection and quantitation of gastrin hormones, including total and free gastrin hormone in a sample. ELISAtype heterogeneous phase assays suitable for use with biological fluid samples such. as blood, plasma or other bodily fluids of a mammal particularly a , human subject are provided. The method provides a precise assay for the amounts of free and total G17 and G34 in biological fluid samples as well as , the amounts of free and total Gly-extended G17 and Gly-extended G34. Also , provided are methods of determining suitable treatment for patient sufféring from a gastrin hormone-mediated disease or condition employing gastrin hormone …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 29, 2004 and granted July 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 29, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 29, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.